Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-45,000
Closed -$1.13M 160
2023
Q2
$1.13M Buy
+45,000
New +$844K 0.36% 91
2022
Q2
Sell
-50,000
Closed -$1.66M 147
2022
Q1
$1.66M Buy
+50,000
New +$1.56M 0.31% 94
2020
Q2
Sell
-1,132
Closed -$17K 180
2020
Q1
$17K Buy
+1,132
New +$32.3K ﹤0.01% 151
2019
Q4
Sell
-30,000
Closed -$1.26M 161
2019
Q3
$1.26M Buy
+30,000
New +$1.26M 0.19% 107
2019
Q2
Sell
-58,000
Closed -$2.86M 162
2019
Q1
$2.86M Buy
+58,000
New +$3.06M 0.4% 57
2018
Q2
Sell
-25,000
Closed -$1.86M 166
2018
Q1
$1.86M Buy
+25,000
New +$2.03M 0.22% 93

Other funds holding EBIX

Formula Growth's EBIX Position: Q3 2023 in Review

Formula Growth sold out of Ebix Inc (EBIX) in Q3 2023, closing a stake of 45,000 shares — an estimated $1.13M sold.

Formula Growth first reported a position in EBIX in Q1 2018 and held it in 6 quarters. The position peaked at $2.86M in Q1 2019. 141 funds tracked by Wall St. Rank hold EBIX as of Q3 2023.

  • Formula Growth reported no remaining Ebix Inc position as of Q3 2023 after selling out during the quarter.
  • Formula Growth sold 45,000 Ebix Inc shares in Q3 2023, an estimated $1.13M.
  • Formula Growth first reported a position in Ebix Inc in Q1 2018 and held it in 6 quarters.
  • Formula Growth's Ebix Inc position peaked at $2.86M in Q1 2019.
  • 141 funds tracked by Wall St. Rank held Ebix Inc as of Q3 2023.

Based on Formula Growth's 13F filing for Q3 2023, filed 13 Nov 2023.